XML 52 R40.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2

EARNINGS PER SHARE AND EQUITY (Tables)

3 Months Ended

Mar. 31, 2024

Earnings Per Share [Abstract]

Schedule of Earnings Per Share, Basic and Diluted

The calculation of basic and diluted LPS is presented below:

			Three Months Ended March 31,
(in thousands, except per share data)			2024						2023
Net loss			$	(50,297)					$	(35,912)
Less: Net loss attributable to non-controlling interests in consolidated subsidiaries			(10,690)						(9,893)
Less: Dividends and accretion of redeemable preferred stock			16,975						14,570
Net loss attributable to stockholders			$	(56,582)					$	(40,589)
Weighted Average Common Stock Outstanding - Basic (1)			104,189,287						102,787,640
Weighted Average Common Stock Outstanding - Diluted (1)			104,189,287						102,787,640
Loss per share:
Basic			$	(0.54)					$	(0.39)
Diluted (2)			$	(0.54)					$	(0.40)

________________________________________________________

(1) Three months ended March 31, 2024 includes penny warrants which can be converted into a fixed amount of our stock.

(2) Diluted LPS for the three months ended March 31, 2024 includes the dilutive effect of subsidiary earnings per share.

Schedule of Stockholders' Equity Note, Warrants or Rights

A summary of the status of the Company’s outstanding stock warrants and changes during the three months ended March 31, 2024 is as follows:

			Number of Warrants						Weighted Average Exercise Price
Outstanding as of December 31, 2023			6,685,132						$	4.93
Issued			—						—
Expired			—						—
Exercised			—						—
Outstanding as of March 31, 2024 (1)			6,685,132						$	4.93
Warrants exercisable as of March 31, 2024 (1)			6,685,132						$	4.93

X

- References

No definition available.

+ Details

Name:	us-gaap_EarningsPerShareAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482662/260-10-50-1

+ Details

Name:	us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-1

+ Details

Name:	us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration